Back to BlackRock Finance, Inc. BlackRock Finance, Inc.

ALPNALPN
3 quarters

Position history for BlackRock Finance, Inc.BlackRock Finance, Inc.'s holdings in ALPINE IMMUNE SCIENCES INC

As of its Q1 2024 13F, BlackRock Finance held 3,575,092 shares of ALPN (Alpine Immune Sciences), worth $141.7M. BlackRock Finance's 13F filings listed ALPN from Q4 2023 to Q1 2024, 2 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$58.3M

Total Shares Change

-3.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q2
Latest
Exited
0
-100.0%
$00.0%—
0
2024-Q1
Increased
3.6M
+16.9%
$141.7M0.0%—
35
2023-Q4
First report
3.1M
-
$58.3M0.0%—
0

Other major holders of ALPN: Avoro Capital Advisors LLC, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used